NDC 42291-634
Oxybutynin ChlorideExtended Release 10 mg tablet, extended release
On the label: AvKARE, Inc.. It's repackaged: AvKARE, Inc. rebottles it from Lannett Company, Inc.'s NDC 62175-271.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Lannett Company, Inc. names for other drugs.
Recalls
- Mar 1, 2019 · Class III · AVKARE Inc.
Failed Dissolution Specifications
Lots: Lots: a) 22738 Exp. 07/2020 and b) 22739 Exp. 07/2020 - Feb 21, 2019 · Class III · Lannett Company Inc.
Failed Dissolution Specifications
Lots: Lots: 18226783A, exp 07/2021 and 18232540A, exp 08/2021
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Oxybutynin: every company that makes it
- Form
- tablet, extended release, oral
- Strength
- 10 mg
- Approval
- ANDA ANDA078503
- On the market since
- Mar 9, 2016
- Package NDCs
42291-634-0142291-634-50- Official label
- DailyMed (National Library of Medicine), updated Dec 16, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?